embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell
07 nov. 2024 06h30 HE
|
Embecta Corp.
embecta will be joined by diabetes advocacy groups to ring the Nasdaq Closing Bell today in recognition of National Diabetes Awareness Month in November.
Biologic Pharmamedical™ Reveals Capryl-Butyrate™ and necessary lifestyle changes for natural solutions for Gut Health, Mental Clarity, and Age-Defying Wellness
04 nov. 2024 17h29 HE
|
Biologic Pharmamedical Inc.
This unveils the crucial role of a balanced microbiome in boosting immunity, metabolism, & mental clarity. Discover how gut health impacts longevity.
RMS Sponsors the 5th Summit on Stem Cell Derived Islets
29 oct. 2024 09h00 HE
|
Regenerative Medical Solutions
Boston, MA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Regenerative Medical Solutions (RMS) is sponsoring the 5th Summit on Stem Cell Derived Islets, which will be held on October 28-29 at the Joseph B....
Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024
29 oct. 2024 07h00 HE
|
Fractyl Health, Inc.
BURLINGTON, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root causes...
Understand the US Type 2 Diabetes Patient Experience for 2023: Demographics, Impact on Quality of Life, Information-seeking Behaviors, HCP Engagement, treatment Awareness and Experiences
24 oct. 2024 04h30 HE
|
Research and Markets
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Type 2 Diabetes in the United States: Understanding the Type 2 Diabetes Patient Experience" report has been added to ResearchAndMarkets.com's...
DXCM DEADLINE NEWS: The October 21 Deadline in DexCom, Inc. Securities Fraud Class Action is Today; Contact BFA Law if You Lost Money (Nasdaq:DXCM)
21 oct. 2024 06h10 HE
|
Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
DXCM DEADLINE ALERT: DexCom, Inc. Investors are Notified of Imminent Monday October 21 Legal Deadline; Contact BFA Law if You Lost Money (Nasdaq:DXCM)
19 oct. 2024 06h31 HE
|
Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
DXCM FRAUD NOTICE: Lost Money on Your DexCom, Inc. Securities? Contact BFA Law by October 21 Deadline in Securities Fraud Class Action (Nasdaq:DXCM)
17 oct. 2024 06h06 HE
|
Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
Eyenuk Teams with the American Academy of Ophthalmology to Provide AI-Driven Eye Disease Screening for Delaware’s Underserved Populations
16 oct. 2024 08h05 HE
|
Eyenuk
Los Angeles, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Eyenuk, a global artificial intelligence (AI) digital health company and the leader in real-world AI Eye Screening™ and AI Predictive Biomarkers™, has...
VedTechBio® Launches RxAgentAI™ – an Artificial Intelligence and Machine Learning Platform, catering to the decision making and strategic needs of stakeholders in the life sciences industry AND VedTechBio® Announces a Drug Discovery Collaboration with RenaissThera®
16 oct. 2024 06h00 HE
|
VedTechBio
VedTechBio launches RxAgentAI – an AI and ML Platform. VedTechBio announces a Drug Discovery Collaboration with RenaissThera.